About 200 reports

  • BIOLOGICS IN IMMUNOLOGY
  • APPROVED IMMUNOLOGY BIOSIMILARS

Biosimilars in Immunology Report Code: GDHCHT## Published: February 2020 Healthcare TABLE OF CONTENTS (##/ ##) ##.

  • Immunology
  • Biocon Limited
  • Biogen Idec Inc.
  • Mylan Inc.
  • Pfizer Inc.

Global Immunology Partnering 2014-2020: Deal trends, players and financials Executive Summary Chapter ## – Introduction Chapter ## – Trends in Immunology dealmaking ##. ##.

  • Immunology
  • Pharmaceutical
  • Therapy
  • United States
  • Demand
  • IMMUNOLOGY MARKET IN EMEA
  • Market size: Global immunology market

You can easily book an appointment with one online.

  • Immunology
  • World
  • AbbVie Inc.
  • Amgen Inc.
  • F. Hoffmann-La Roche Ltd.
  • A) Global immunology market size
  • A) Global immunology market split

Only one JAK inhibitor, Xeljanz, is approved for the immunology market.

  • Immunology
  • AbbVie Inc.
  • Eli Lilly & Co.
  • Janssen Biotech, Inc.
  • Johnson & Johnson
  • IMMUNOLOGY INFLUENCERS AND COVID-19 CONTENT: MAY 2020
  • Top COVID-19 Posts by Immunology Influencers: 'Asthma' and 'Respiratory'

Immunology Influencers IMMUNOLOGY INFLUENCERS AND COVID-## CONTENT: MAY 2020 THERE WAS A DECREASE IN IMMUNOLOGY INFLUENCER COVID-## TWEETS IN MAY 2020.

  • Hospital
  • Immunology
  • Infectious Disease
  • United States
  • Gilead Sciences, Inc.
  • IMMUNOLOGY INFLUENCERS AND COVID-19 CONTENT: APRIL 2020
  • CHANGES IN COMPANY TYPE MENTIONED IN IMMUNOLOGY COVID-19 POSTS (APRIL 2020)

Immunology Influencers IMMUNOLOGY INFLUENCERS AND COVID-## CONTENT: APRIL 2020 THERE WAS A SLIGHT CHANGE IN IMMUNOLOGY INFLUENCER COVID-## TWEETS IN APRIL 2020.

  • Endocrine Disease
  • Hospital
  • Immunology
  • Infectious Disease
  • United States

Business Overview Product Portfoilio Financials SWOT Analysis FUTURE OUTLOOK OF THE MARKET ABBREVIATIONS APPENDIX: PRESS RELEASES Chart List List of Charts: Europe Immunology Market Size, 2013 - 2023 (US$M) Europe Immunology Market Size, by Region, 2013 - 2023 (US$M) Europe

  • Health Services
  • Immunology
  • Therapy
  • Europe
  • Market Size

Business Overview Product Portfoilio Financials SWOT Analysis FUTURE OUTLOOK OF THE MARKET ABBREVIATIONS APPENDIX: PRESS RELEASES Chart List List of Charts: Brazil Immunology Market Size, 2013 - 2023 (US$M) Brazil Immunology Market Size, by Region, 2013 - 2023 (US$M) Brazil

  • Immunology
  • Brazil
  • BRIC
  • China
  • Market Size
  • 3.4.4 Immunology
  • D) Immunology

The drug claimed blockbuster status just one year after its launch.

  • Immunology
  • Pharmaceutical
  • Therapy
  • Company
  • Market Size

Immunology Departmental SystemLaboratory Information SystemDigital Nutritional SystemFinancial Management SoftwareDigital Referral SystemShift Management Hospital Health Monitoring SystemProcess AutomationDose Archiving and Communication SystemClinical Decision Support and Patient RiskSteri

  • Health Services
  • Immunology
  • Europe
  • Demand
  • Supply
  • 4.2.4 Immunology
  • 3.4.4 Immunology

Health Affairs; ##(##): ##-## Vernon J, et al. (2010).

  • Clinical Trial
  • Immunology
  • Pharmaceutical
  • Therapy
  • Market Size
  • La Jolla Institute for Allergy & Immunology - Key Competitors
  • La Jolla Institute for Allergy & Immunology, Key Competitors

GlobalData La Jolla Institute for Allergy & Immunology reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Allergy
  • Chronic Disease
  • Immunology
  • United States
  • Deals & Alliance
  • Institute for Research in Immunology and Cancer, Key Employees
  • Institute for Research in Immunology and Cancer - Key Competitors

GlobalData Therapy Area Central Nervous System Gastrointestinal Immunology Infectious Disease Metabolic Disorders Oncology No. of Deals ## ## ## ## ## ## Deal Value (US$ million) NA NA NA NA NA NA Institute for Research in Immunology and Cancer, Medical Devices

  • Healthcare
  • Immunology
  • Pharmaceutical
  • Therapy
  • Canada
  • IMMUNOLOGY DRUGS MARKET, 7MM, EPIDEMIOLOGY OF KEY IMMUNOLOGY INDICATIONS, 2018
  • IMMUNOLOGY DRUGS MARKET, GLOBAL, PIPELINE FOR KEY IMMUNOLOGY INDICATIONS BY

Cellular Immunology; ##(##): ##-## Webster AC, et al. (2005).

  • Healthcare
  • Immunology
  • Monoclonal Antibody
  • Company Financials
  • Forecast
  • PROPORTION OF CORNEAL GRAFT REJECTION TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2019*
  • PROPORTION OF CORNEAL GRAFT REJECTION TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2019*

The prominent features of this report are - ##.

  • Immunology
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • Immunology, Multiple Sclerosis, Non- Alcoholic Steatohepatitis
  • SMALL MOLECULES TO ANTAGONIZE ROR GAMMA FOR GASTROINTESTINAL AND IMMUNOLOGY DISORDERS - DRUG PROFILE

One patient has a confirmed partial response (cPR) and is ## of ## patients that remain on study.

  • Autoimmune Disease
  • Immunology
  • United States
  • World
  • Product Initiative
  • 6.4 PHARMACEUTICALS & HEALTHCARE, GLOBAL, IMMUNOLOGY DEALS, Q2 2019
  • Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$

One ADS right entitles an ADS holder to subscribe for and purchase one new ADS.

  • Dermatology
  • Immunology
  • World
  • Company
  • Deals & Alliance
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF MYASTHENIA GRAVIS TO IMMUNOLOGY CLINICAL TRIALS
  • PROPORTION OF MYASTHENIA GRAVIS TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2020*

Hoffmann-La Roche Ltd Cytokinetics Inc ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## UCB SA Roivant Sciences Ltd Argenx SE ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Amarin Corp Plc ## ## ## ##

  • Drug Development
  • Immunology
  • Pharmaceutical
  • World
  • Product Initiative
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF HEART TRANSPLANT REJECTION TO IMMUNOLOGY CLINICAL TRIALS
  • PROPORTION OF HEART TRANSPLANT REJECTION TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2020*

The prominent features of this report are - ##.

  • Clinical Trial
  • Heart Transplant
  • Immunology
  • Transplantation
  • Novartis AG
  • ANTISENSE OLIGONUCLEOTIDE TO ANTAGONIZE ROR GAMMA FOR IMMUNOLOGY - DRUG PROFILE
  • SMALL MOLECULES TO ANTAGONIZE ROR GAMMA FOR GASTROINTESTINAL AND IMMUNOLOGY DISORDERS - DRUG PROFILE

One patient has a confirmed partial response (cPR) and is ## of ## patients that remain on study.

  • Immunology
  • United States
  • World
  • Product Initiative
  • Lycera Corp.
  • PROPORTION OF HEMATOPOIETIC STEM CELL TRANSPLANTATION TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2020*
  • PROPORTION OF HEMATOPOIETIC STEM CELL TRANSPLANTATION TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2020*

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Blood Disease
  • Immunology
  • Medical Biotechnology
  • World
  • Product Initiative
  • Proportion of Liver Transplant Rejection to Immunology Clinical Trials, E7 Countries (%), 2020*
  • Proportion of Liver Transplant Rejection to Immunology Clinical Trials, G7 Countries (%), 2020*

The prominent features of this report are - ##.

  • Clinical Trial
  • General Medicine And Specialty Medicine
  • Immunology
  • Liver Transplant
  • World
  • PROPORTION OF PEANUT ALLERGY TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2020*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF PEANUT ALLERGY TO IMMUNOLOGY CLINICAL TRIALS

The prominent features of this report are - ##.

  • Allergy Immunotherapy
  • Immunology
  • Medical Biotechnology
  • World
  • Product Initiative
  • Proportion of Stem Cell Transplantation to Immunology Clinical Trials, G7 Countries (%), 2019*
  • Proportion of Stem Cell Transplantation to Immunology Clinical Trials, E7 Countries (%), 2019*

The prominent features of this report are - ##.

  • Drug Development
  • General Medicine And Specialty Medicine
  • Immunology
  • World
  • Product Initiative
  • 4.4 PHARMACEUTICALS & HEALTHCARE, GLOBAL, IMMUNOLOGY DEALS, 2017
  • Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), 2014 - 2018

AVXS-##, has highly compelling clinical data in treating SMA Type ##, which is the number one genetic cause of death in infants.

  • Endocrine Disease
  • Immunology
  • World
  • Company
  • Deals & Alliance
  • PROPORTION OF SICCA SYNDROME (SJOGREN) TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2018*
  • PROPORTION OF SICCA SYNDROME (SJOGREN) TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2019*

Hoffmann-La Roche Ltd GlaxoSmithKline Plc ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Galapagos NV ## ## ## ## ## ## UCB SA ## ## ## ## ## ## Pamplona Capital Management LLP ## ## ## ## ## ## Kadmon Holdings Inc ## ##

  • Clinical Trial
  • Immunology
  • Monoclonal Antibody
  • World
  • Novartis AG
  • PROPORTION OF CHURG-STRAUSS SYNDROME TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2019*
  • PROPORTION OF CHURG-STRAUSS SYNDROME TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2019*

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Immunology
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • PROPORTION OF LUPUS NEPHRITIS TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2019*
  • CLINICAL TRIALS BY E7 COUNTRIES: PROPORTION OF LUPUS NEPHRITIS TO IMMUNOLOGY CLINICAL TRIALS

The prominent features of this report are - ##.

  • Clinical Trial
  • Hospital
  • Immunology
  • World
  • Product Initiative
  • PROPORTION OF CHRONIC INFLAMMATION TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2019*
  • CLINICAL TRIALS BY G7 COUNTRIES: PROPORTION OF CHRONIC INFLAMMATION TO IMMUNOLOGY CLINICAL TRIALS

The prominent features of this report are - ##.

  • Immunology
  • Monoclonal Antibody
  • World
  • Product Initiative
  • Synergenics, LLC
  • PROPORTION OF DRUG HYPERSENSITIVITY REACTIONS TO IMMUNOLOGY CLINICAL TRIALS, G7 COUNTRIES (%), 2019*
  • PROPORTION OF DRUG HYPERSENSITIVITY REACTIONS TO IMMUNOLOGY CLINICAL TRIALS, E7 COUNTRIES (%), 2019*

The prominent features of this report are - ##.

  • Clinical Trial
  • Immunology
  • Therapy
  • World
  • Product Initiative